Eloxx Pharmaceuticals Inc (ELOX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2006 | 03-2006 | 12-2005 | 09-2005 | 06-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 310 | 440 | 80 | 580 | 290 |
| Marketable Securities | 850 | 2,070 | 2,940 | 3,130 | 3,940 |
| Other current assets | 140 | 80 | 70 | 130 | 160 |
| TOTAL | $1,300 | $2,590 | $3,090 | $3,840 | $4,390 |
| Non-Current Assets | |||||
| Investments And Advances | 0 | 0 | 7 | 0 | 240 |
| Other Non-Current Assets | 2,217 | 1,957 | 1,750 | 1,597 | 1,437 |
| TOTAL | $2,217 | $1,957 | $1,757 | $1,597 | $1,677 |
| Total Assets | $3,530 | $4,570 | $4,870 | $5,460 | $6,110 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 70 | 140 | 100 | 140 | 210 |
| Accrued Expenses | 330 | 590 | 390 | 270 | 180 |
| Other current liabilities | 40 | 40 | 9 | 20 | 30 |
| TOTAL | $440 | $790 | $500 | $430 | $430 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 130 | 120 | 100 | 100 | 90 |
| TOTAL | $130 | $120 | $100 | $100 | $90 |
| Total Liabilities | $580 | $920 | $610 | $530 | $520 |
| Shareholders' Equity | |||||
| Common Shares | 150 | 150 | 150 | 150 | 150 |
| Retained earnings | -22,370 | -21,580 | -20,860 | -19,950 | -14,760 |
| Other shareholders' equity | 10 | 10 | 0 | 0 | 10 |
| TOTAL | $2,950 | $3,650 | $4,260 | $4,930 | $5,590 |
| Total Liabilities And Equity | $3,530 | $4,570 | $4,870 | $5,460 | $6,110 |